Asthma/COPD Flashcards
Obstructive Chest Conditions:
disturbance of ventilation due to increased resistance to airflow in the airways (Asthma/COPD
Restrictive Chest Conditions:
disturbance of ventilation due to decreased chest wall or lung movement (fibrosis)
What are the selected obstructive chest disorders?
- Asthma
- COPD-Chronic Bronchitis, Emphysema
- Atelectasis
- Consolidation
What are the first five symptoms of obstructive chest disease?
- Chest pain
* 2. Dyspnea*
* 3. Wheezing*
* 4. Cough* - Hemoptysis
What is the etiology of dyspnea?
difficulty breathing
1. CV (left-sided heart failure)
2. Lungs (asthma, COPD, pneumonia)
3. Anxiety
SOB related to activity vs. difficulty taking deep breaths, smothering sensation, paresthesia
What is the etiology of wheezing?
- relatively high pitched adventitious sounds with hissing or shrill, musical quality*
1. May be audible without stethoscope
2. Etiology: narrowed bronchi
What is etiology of cough?
Reflex response to endogenous or exogenous irritants in larynx, trachea, or large bronchi (lung/heart disease)
- Dry vs. productive cough
- If productive, volume, color, odor, consistency important
What are pulmonary function tests used for?
- help d/x and determine severity of chest conditions
2. monitor patients with chest conditions (disease progression, effect of treatment)
What does a pulmonary function test assess?
- Lung volumes
- Air flows rates
- Gas exchange
What is spirometry?
- Measurement of breathing*
1. Used to measure volumes/capacities and flow rates
How do you complete spirometry?
- Pt. inhales maximally, then exhales forcibly and completely into spirometer
- May continue through maximal forced inspiration, depending on test performed
- May record volume as function of time as function of volume
Why use spirometry in obstruction?
individuals have a reduced ability to move air through the conducting airways of the lung (Asthma, COPD)
Why use spirometry in restriction?
individuals have most difficulty getting air into the lung and typically have decreased lung volumes (fibrosis)
Spirometry: FEV1
forced expiratory volume in first second of expiration
- -pre/post bronchiodilator
- ->12% improved = asthma
Spirometry: FVC
forced vital capacity
-helpful to determine fixed obstruction
Spirometry: TLC
total lung capacity
Spirometry: RV
residual volume (left after FVC)
Spirometry: DLco
diffusing capacity for carbon monoxide
Spirometry: FEV1/FVC
ratio to standardized and interpret results
Normal: > 75%
What effective do obstructive processes have on spirometry parameters?
decrease airway flow rates with relative preservation of forced vital capacity
What effective do restrictive processes have on spirometry parameters?
decreased forced vital capacity with relative preservation of flow rates
If disease is likely check the spirometry % FEV1/FCV:
- If the ratio 88-90% or higher = restrictive disease likely
- If the ratio is <75% = obstructive disease likely
What occurs with FEV1/FVC in asthma?
<75%
What occurs with FEV1/FVC in COPD?
<75%
What is asthma?
- a heterogenous clinical disorder characterized by episodic wheezing and hyper-responsiveness of the airway to a variety of stimuli
- largely reversible obstruction of the airways
- inflammation is present in the airways and over time remodeling may occur that in turn can cause permanent structural changes and decline liver function
What are the smooth muscle dysfunctions that occur during asthma?
- bronchoconstriction
- bronchial hyperreactivity
- hypertrophy/hyperplasia
- inflammatory mediator release
What airway inflammation occurs during asthma?
- inflammatory cell infiltration/activation
- mucosal edema
- cellular proliferation
- epithelial damage
- basement membrane thickening
What factors can lead to pre symptomatic/early disease and then onto clinical asthma?
- Genetic/host susceptibility for asthma
2. Environmental exposures, allergens, air pollutants, viral infections
what happens to the lung morphology in asthma?
- Bronchial inflammation
- Edema, mucus plugging
- Bronchospasm
- Obstruction
- Over inflation/atelectasis
- Characteristic of COPD
What is the notable micro pathology of asthma?
- Patchy necrosis of epithelium
- Sub-mucosal glandular hyperplasia
- Hypertrophy of bronchial SM
- Eosinophils, mast cells, lymphocytes
- Mucous plugs
What happens in the bronchial tissue in patients with asthma?
- Inflammation
- Eosinophils
- Gland hyperplasia
- Mucous plug in lumen
- Hypertrophy of muscle layer
What happens at the cellular level in asthma?
- Initiated by allergens
- Recruited to airway by other inflammatory cells
- Perpetuate tissue damage and inflammation (mast, Th2, eosinophils, neutrophils)
What are characteristic features of persistent asthma?
- Denudation of airway epithelium
- Collagen deposition beneath basement membrane
- Mast-cell degranulation
- Lymphocyte and eosinophil infiltration
- Release of cytokines and chemokines
What are the most common predisposing factors associated with asthma?
- History of atopy
- Initiation of asthma in early life
- Respiratory viral infections
- Exposure to airborne allergens
- Positive family history
Normal FEV1
> 80%
Normal FVC
> 80%
Mild obstruction FEV1/FVC and FEV1
<75%
70-100%
Moderate obstruction FEV1/FVC and FEV1
<75%
60-70%
Moderate/severe obstruction FEV1/FVC and FEV1
<75%
50-60%
Severe obstruction FEV1/FVC and FEV1
<75%
34-50%
well controlled asthma
- symptoms
- nighttime awakenings
- interference with normal activity
- SABA use
- FEV1 or peak flow
- exacerbations
- <2 days/week
- <2/month
- none
- <2 days/week
- > 80% predicted/personal best
- 0-1 per year
Not well controlled asthma
- symptoms
- nighttime awakenings
- interference with normal activity
- SABA use
- FEV1 or peak flow
- exacerbations
- > 2 days/week
- 1-3 per week
- some limitation
- > 2 days/week
- 60-80% predicted/personal best
- 2-3 per year
Very poorly controlled asthma
- symptoms
- nighttime awakenings
- interference with normal activity
- SABA use
- FEV1 or peak flow
- exacerbations
- Throughout the day
- > 4/week
- extremely limited
- several times per day
- <60% predicted/personal best
- > 3 per year
Questionnaires for asthma
ATAQ (asthma therapy assessment questionnaire)
ACQ (asthma control questionnaire)
ACT (asthma control test)
Well controlled asthma
- ATAQ
- ACQ
- ACT
- 0
- <0.75
- > 20
Not well controlled asthma
- ATAQ
- ACQ
- ACT
- 1-2
- > 1.5
- 16-19
Very poorly controlled asthma
- ATAQ
- ACQ
- ACT
- 3-4
- N/A
- <15
Indirect costs of asthma
$5 billion
- lost productivity at work
- schooldays lost
- mortality
Direct costs of asthma
$14.7 billion
- hospital care
- physical and other health services
- Rx meds
Treatment success of asthma
- no missed school/work days
- no sleep disruption
- maintain normal activity levels
- no (or minimal) ER visits
- normal or near normal lung function
Severity
intrinsic intensity of disease
Control
degree to which asthma is minimized
Responsiveness
ease with which asthma control is achieved
impairment
frequency and intensity of symptoms and functional limitations
risk
likelihood of either exacerbations, progressive decline in lung function or risk of ADEs from meds
When is spirometry recommended for asthma?
- at initial assessment
- during stabilization phase PRN
- after treatment has stabilized symptoms
- at least every 1-2 years
When FEV1 increases ____% after using SABA this is reversible
12
Additional tests for asthma
- bronchoprovocation (Histamine challenge, methacholine challenge)
- exercise/treadmill testing
Alternative strategies for asthma
- FENO
- sputum eosinophils
- videolaryngostroboscopy
- chest X ray
- allergy skin test
What are common comorbidities that can aggravate asthma?
VCD
GERD
allergic rhinitis
Symptom history for asthma should be based on what?
2-4 week recall period
How do you monitor lung function in asthma?
peak flow monitoring
Red zone
<50%
Yellow zone
50-80%
Green zone
80-100%
t/f partnership in asthma care is important
true
A key principle of pharmacologic care in asthma is
regulation of chronic airway inflammation
In general ____ medication is superior to ____ in asthma control
inhaled
Oral or IV
Low dose fluticasone MDI
88-24 mcg
44 mcg per puff = 1-3 puffs/day
Medium dose fluticasone MDI
264 - 440 mcg
110 mpg/puff = 2 puffs BID
220 mcg/puff = 1 puff BID
High dose fluticasone MDI
> 440mcg
110mcg/puff = 3 puffs BID
220 mcg/puff = 2 or more puffs BID
Low dose fluticasone DPI
100 - 300mcg
50mcg per inhaler = 1-3 BID